Multicentric reticulohistiocytosis.
| dc.contributor.author | Coupe, M O | |
| dc.contributor.author | Whittaker, S J | |
| dc.contributor.author | Thatcher, Nick | |
| dc.date.accessioned | 2010-07-21T09:51:12Z | |
| dc.date.available | 2010-07-21T09:51:12Z | |
| dc.date.issued | 1987-02 | |
| dc.identifier.citation | Multicentric reticulohistiocytosis. 1987, 116 (2):245-7 Br. J. Dermatol. | en |
| dc.identifier.issn | 0007-0963 | |
| dc.identifier.pmid | 3828217 | |
| dc.identifier.doi | 10.1111/j.1365-2133.1987.tb05821.x | |
| dc.identifier.uri | http://hdl.handle.net/10541/108027 | |
| dc.description.abstract | A case of multicentric reticulohistiocytosis associated with a pleural mesothelioma is reported. The cutaneous and joint manifestations resolved after treatment with cyclophosphamide, and the remission persisted until the patient's death 3 years later. As corticosteroids have such an unpredictable effect on this condition, cyclophosphamide may be regarded as the treatment of choice until more cases can be assessed. | |
| dc.language.iso | en | en |
| dc.subject | Multi Primary Cancer | en |
| dc.subject | Pleural Cancer | en |
| dc.subject | Skin Cancer | en |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Lymphatic Diseases | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Mesothelioma | |
| dc.subject.mesh | Neoplasms, Multiple Primary | |
| dc.subject.mesh | Pleural Neoplasms | |
| dc.subject.mesh | Skin Neoplasms | |
| dc.subject.mesh | Synovial Membrane | |
| dc.title | Multicentric reticulohistiocytosis. | en |
| dc.type | Article | en |
| dc.contributor.department | Department of Medicine, Wythenshawe Hospital, Southmoor Road, Manchester. U.K. | en |
| dc.identifier.journal | The British Journal of Dermatology | en |
| html.description.abstract | A case of multicentric reticulohistiocytosis associated with a pleural mesothelioma is reported. The cutaneous and joint manifestations resolved after treatment with cyclophosphamide, and the remission persisted until the patient's death 3 years later. As corticosteroids have such an unpredictable effect on this condition, cyclophosphamide may be regarded as the treatment of choice until more cases can be assessed. |